ライフサイエンスコーパス: organ donor

1 message in the video (becoming a registered organ donor).

2 and age-dependent probability of becoming an organ donor.

3 willingness of individuals to be a deceased organ donor.

4 thyroid hormone in the brain-dead potential organ donor.

5 tigations, LCMV could not be detected in the organ donor.

6 different anatomic compartments in six human organ donors.

7 Upper limbs were procured from brain-dead organ donors.

8 acini isolated from cadaveric pancreata from organ donors.

9 n regarding the number of potential deceased organ donors.

10 Only half of Americans register as organ donors.

11 disc cells isolated from healthy, pain-free organ donors.

12 ry (registrants) and their value in terms of organ donors.

13 gistrants, 32% of the sample were registered organ donors.

14 e compared with those from three nondiabetic organ donors.

15 the DonateLife Audit of whom 553 (8.1%) were organ donors.

16 nt psychosocial screening programs of living organ donors.

17 ed States and may account for 3% of deceased organ donors.

18 there continues to be a critical shortage of organ donors.

19 quency of false-positive results in deceased organ donors.

20 possible to estimate the expected number of organ donors.

21 ific for the identification of survivors and organ donors.

22 psychosocial evaluation for eligible living organ donors.

23 mucosal tissues obtained from 56 individual organ donors.

24 on the nonprocurement of kidneys from solid organ donors.

25 rs per 100 eligible deaths were converted to organ donors.

26 nt screening practices of potential deceased organ donors.

27 explained etiology, especially for potential organ donors.

28 tive than NAT for the screening of potential organ donors.

29 in kidney allograft recipients and deceased organ donors.

30 , particularly when patients were registered organ donors.

31 n of thyroid hormone to brain-dead potential organ donors.

32 from DCD and donors after brain death (DBD) organ donors.

33 ations for screening and management of TB in organ donors.

34 ght patients with CHI and from adult cadaver organ donors.

35 ancreas was not recovered in 48% (11,820) of organ donors.

36 1 may serve to increase the pool of eligible organ donors.

37 btained from the knee and ankle joints of 34 organ donors.

38 ation today is how to increase the number of organ donors.

39 asingly obese, so does the pool of potential organ donors.

40 ed the way centers were notified of possible organ donors.

41 s to encourage consideration of all possible organ donors.

42 e oxygenation more than placebo in hypoxemic organ donors.

43 y Program for Reimbursing Expenses of Living Organ Donors.

44 peripheral blood of 135 intended and actual organ donors.

45 C patients, compared to control samples from organ donors.

46 A total of 119 patients became actual organ donors.

47 work database from 2000 to 2012 of all solid organ donors.

48 hand) was performed in 9 human heart-beating organ donors.

49 tines) sites from a population of brain-dead organ donors (2 months-93 years; n = 291) across eight c

50 f T. cruzi antibodies in Southern California organ donors, 404 samples from deceased organ donors bet

51 potential donors proceeding to become actual organ donors (64% vs 75%, P = 0.007).

52 Those registered as organ donor (69.8%) had better knowledge, perceptions, a

53 nial hemorrhage than were all other deceased organ donors (85% vs. 57%, p < 0.001).

54 plant recipients developed encephalitis from organ donor-acquired lymphocytic choriomeningitis virus.

55 as the main pillars), in selected potential organ donors after brain death increased lung eligibilit

56 Given the stable number of potential organ donors after brain death, donors after circulatory

57 Twelve patients who were pediatric organ donors after cardiac death.

58 ecessarily translate to individuals becoming organ donors after death.

59 pothermia, as compared with normothermia, in organ donors after declaration of death according to neu

60 We enrolled organ donors (after declaration of death according to ne

61 improve the identification and reporting of organ donors aiming at an annual rate of 15 donors per m

62 ransplantation, making the care of potential organ donors an important issue.

63 Organ donor and all transplant recipient medical records

64 ebrospinal fluid, and urine samples from the organ donor and recipients were tested for WNV infection

65 es have the potential to instrumentalize the organ donor and that they should be restricted to cases

66 We reviewed the medical records of the organ donor and the recipients.

67 We reviewed medical records of the organ donor and transplant recipients and tested serum,

68 To minimize variables associated with the organ donor and with tissue processing, all of the graft

69 We recruited 30 consecutive brain-dead organ donors and 78 recipients between April 11, 2004, a

70 eatic immune cell characteristics in control organ donors and CP patients including those with heredi

71 nce of anti-HTLV I/II antibodies among solid organ donors and determine the number of false positive

72 atory response characteristics in brain-dead organ donors and examine associations with organ transpl

73 the islet-infiltrating T cells of pancreatic organ donors and in the peripheral blood of individuals

74 eload responsiveness is common in brain-dead organ donors and is associated with higher inflammatory

75 The second cohort consisted of prior organ donors and matched nondonors who underwent decease

76 The first cohort consisted of prior organ donors and matched nondonors who were wait-listed

77 per year over the last 3 years from deceased organ donors and pancreatectomized patients, respectivel

78 As the gap between organ donors and patients on the recipient waiting list

79 We characterized CD8 T cells derived from organ donors and patients with end-stage HCV infection t

80 Universal screening of potential organ donors and recipients for severe acute respiratory

81 endothelial glycocalyx breakdown products in organ donors and recipients in terms of acceptability fo

82 HHV-8 status can be useful when considering organ donors and recipients with risk factors, although

83 However, the extreme shortage of matched organ donors and the necessity for chronic immunosuppres

84 try needs to increase the number of deceased organ donors and the potential impact of a change to opt

85 legislation and its benefits for registered organ donors and their families.

86 lasma virus in four genotype 1a HCV-positive organ donors and their seven organ recipients to assess

87 cs and risk factors for ZIKV infection among organ donors and transplant outcomes among recipients of

88 sues were selected from groups of nonfailing organ donors and transplant recipients with endstage isc

89 derstood about SARS-CoV-2 and how it affects organ donors and transplant recipients.

90 in human islets obtained from deceased adult organ donors and transplanted them into hyperglycemic, i

91 NV infections among recipients from the same organ donor, and remove any potentially infected blood p

92 ent acquisition of HIV by prospective living organ donors, and to conduct HIV antibody testing and NA

93 vels of cf-mt-DNA elevated in older deceased organ donors, and with the isolated cf-mt-DNA capable of

94 were also those who would be unlikely to be organ donors anyway, because they tended to hold negativ

95 on is needed and additional vessels from the organ donor are not available.

96 for such studies and the fact that deceased organ donors are not covered by extant federal regulatio

97 ungs from otherwise eligible brain dead (BD) organ donors are not transplanted.

98 Organ donors are often implicated as the source of postt

99 Deceased organ donors are routinely screened for behaviors that i

100 policy requires that all potential deceased organ donors are screened for human immunodeficiency (HI

101 Organ donors are sources of physiologically healthy orga

102 Organ donors are tested for anti-HTLV antibodies and don

103 tion is not uncommon as approximately 23% of organ donors are uninsured.

104 This has significant implications for organ donors as the lungs from patient's dying of ischem

105 ed its platform to allow members to specify "Organ Donor" as part of their profile.

106 al brush border membrane vesicles from human organ donors, as well as in HEK293 cells stably transfec

107 BD organ donors at 4 organ procurement organizations were r

108 tions related to management of the potential organ donor, based on the available literature and exper

109 from the costal diaphragms of 14 brain-dead organ donors before organ harvest (case subjects) and co

110 The effect that targeted mild hypothermia in organ donors before organ recovery has on the rate of de

111 There were 10 facial VCA procurements in organ donors between December 2008 and October 2014.

112 rnia organ donors, 404 samples from deceased organ donors between May 2002 to April 2004 were screene

113 Conditioning the brain-dead organ donor by altering metabolism could be a novel appr

114 Current screening of deceased organ donors by RPR yields a significant number of false

115 Hormonal therapy to the brain-dead potential organ donor can include thyroid hormone (triiodothyronin

116 In all, tested organs donor cells undergo "licensing" for pathogenicity

117 from patients undergoing transplantation or organ donors (CF samples=18; non-CF, nonbronchiectatic s

118 is strongly increased in a subgroup of human organ donors characterized by prolonged duration of stay

119 Household income was a predictor of organ donor consent only in whites.

120 r(s) associated with both race and obtaining organ donor consent.

121 be applied at any institution with access to organ donors consenting to tissue donation for research,

122 The ethical debate of advertising for organ donors continues.

123 man AAA tissue samples compared with that in organ donor controls.

124 e status of both the organ recipient and the organ donor critically influences allograft outcome.

125 e a 10-minute video that featured registered organ donors, deceased donor families, and transplant re

126 and lymphoid tissues of T1D and nondiabetic organ donors differ in the amount and distribution of HA

127 To overcome the scarcity of organ donors, elderly RT candidates should be encouraged

128 We reviewed data from the pretransplant organ donor evaluation and local EEEV surveillance.

129 In conclusion, these data suggest that prior organ donors experience brief waiting time for kidney tr

130 lear cause of death in a potential pediatric organ donor, factors such as parental consanguinity shou

131 mission of melanoma by apparent disease-free organ donors following removal of a primary melanoma up

132 seeking organ transplantation and serving as organ donors for HIV-positive recipients, HHV-8 prevalen

133 The shortage of organ donors for kidney transplants has made the expansi

134 S. policy requires screening of all deceased organ donors for syphilis infection.

135 The severe shortage of organ donors for treating patients with liver disease ha

136 ively identified all successful US DCD solid organ donors from 1/2011 to 3/1/2017, defined an ideal h

137 We identified all UK deceased organ donors from 2003 to 2015 with a disclosed history

138 Twenty-one deceased organ donors had a predonation diagnosis of ITP.

139 At trial termination, 370 organ donors had been enrolled (180 in the hypothermia g

140 tion (CPR) of a person destined to become an organ donor has been associated with overall poor donor

141 The number of deceased organ donors has increased from 709 (12.0 per million po

142 The current shortage of organ donors has led many centers to use marginal and no

143 the bone marrow (BM) of heparinized deceased organ donors (HDODs).

144 abolic tissues from previously healthy human organ donors, here we have provided a map of human ILC h

145 Antibodies that are specific to organ donor HLA have been involved in the majority of ca

146 o represent an underused source of potential organ donors; however, there is a paucity of data regard

147 ct to ICOD were finally medically unsuitable organ donors.ICOD contributed to 24% of the 491 actual d

148 imary outcome measure was potential deceased organ donors (identified by the presence of diagnostic c

149 , we tested 1,408 specimens from prospective organ donors in 2002 and 2003.

150 to estimate the number of potential deceased organ donors in Canada.

151 kistan, Egypt, and the Philippines, deceased organ donors in Colombia, and executed prisoners in Chin

152 <18 years) can ethically serve as live solid organ donors in exceptional circumstances.

153 f a multidisciplinary approach for potential organ donors in the emergency department (ED) in order t

154 ucosal tissue T cells derived from pediatric organ donors in the first two years of life, as compared

155 Improving the management of potential organ donors in the intensive care unit could meet an im

156 .8 per million of population [pmp]) deceased organ donors in the United Kingdom from 1999 to 2009.

157 % of the increase in the numbers of deceased organ donors in the United Kingdom.

158 2013 modification, over 20% of all deceased organ donors in the United States were identified as PHS

159 uidelines and no data on the incidence among organ donors in the US.

160 Twenty-nine percent of the total pool of organ donors in these hospitals were admitted to the ICU

161 g (RNA-seq) on islets from multiple deceased organ donors, including children, healthy adults, and in

162 ed blood transfusion as a possible source of organ donor infection by testing remaining components an

163 On the first day of the Facebook organ donor initiative, there were 13 054 new online reg

164 lantation of undetected (occult) cancer from organ donor into immunosuppressed recipients.

165 nt or undiagnosed active TB in the potential organ donor is critical to prevent emergence of disease

166 es show that simvastatin administered to the organ donor is vasculoprotective and inhibits cardiac al

167 virus type 1 (HTLV-1) screening of blood and organ donors is not mandatory in Germany because of its

168 performed, and the number of false positive organ donors is unknown.

169 nor's participation in the study, ended when organ donors left the intensive care unit for organ reco

170 Our results reveal that organ donors maintain tissue homeostasis, and are a valu

171 We studied a cohort of 1872 potential organ donors managed by the California Transplant Donor

172 after brain stem herniation in 980 potential organ donors managed by the California Transplant Donor

173 A total of 1043 organ donors managed from 2001-2006 were initially studi

174 orating expertise in critical care medicine, organ donor management, and transplantation.

175 Many of the common ECG abnormalities seen in organ donors may result from the heightened state of sym

176 increasing the willingness to be a deceased organ donor (measured as commitment to donate and/or int

177 All surgeons operating on a living organ donor must select vascular control techniques that

178 iac artery vessels were harvested from liver organ donors (n=8).

179 The New York Organ Donor Network (NYODN) established an Infectious Di

180 , matched normal adjacent to tumor (AT), and organ donor (OD).

181 little experience with caring for potential organ donors (odds ratio, 1.49; 95% CI, 1.09-2.04).

182 0.32-0.53; p < 0.001), more often potential organ donors (odds ratio, 1.92; 95% CI, 1.56-2.35; p < 0

183 Among brain-dead organ donors, older age donors contribute fewer organs f

184 of the 8 blood products transfused into the organ donor or in products derived from these donations.

185 er gram of human liver (n = 6) obtained from organ donors or directly from surgery is, on average, le

186 about the expected ECG findings in potential organ donors or the clinical significance of any identif

187 , glucagon, lipase, and/or trypsinogen in 78 organ donor pancreata from birth through adulthood in co

188 ning hundreds of thousands of cells in human organ donor pancreata, we show that quantitative graph c

189 terviews were conducted with 16 relatives of organ donor patients and with eight relatives of nonorga

190 novel therapeutic approaches to maximize the organ donor pool through the safer use of liver transpla

191 t of recommendations aimed at maximizing the organ donor pool while safeguarding the interests of pot

192 f IRI, to improve liver function, expand the organ donor pool, and improve the overall success of liv

193 DT) may play an important role in increasing organ donor pool.

194 ther staff in intensive care units with high organ donor potential.

195 e Program for Reimbursing Expenses of Living Organ Donors (PRELOD) was launched in the province of On

196 In this study, we used a human organ donor preparation method to measure human ipRGCs'

197 tissues adjacent to tumor, and 4 age-matched organ-donor prostate tissues.

198 ostate tissues, matched blood specimens, and organ donor prostates.

199 ent to tumor, in comparison with age-matched organ-donor prostates.

200 eas transplant but because of differences in organ donor, recipient, and transplant characteristics.

201 ering the absence of systematic screening of organ donors/recipients for HHV-8 infection, HHV-8-relat

202 er their donation decision on the Australian Organ Donor Register (AODR) in their own time, yet <30%

203 Previous discussion and Organ Donor Register (ODR) enrollment both correlate wit

204 ue Act (2004) should be removed, and (7) the Organ Donor Register should be expanded to include poten

205 omoting organ donation resulted in increased organ donor registration at the DMV.

206 ed state identification card demographic and organ donor registration data from 5 states to estimate

207 Within the student organization, organ donor registration increased by 28%.

208 , motivated 19 623 people to go to a state's organ donor registration page, and had 9000 documented o

209 h 0.1 decrease in the deprivation index, the organ donor registration rate increased by 6.8% (95% con

210 dicate predominantly white neighborhoods) on organ donor registration rates within a specified geogra

211 onomic deprivation and racial segregation on organ donor registration rates.

212 concentration of white residents have higher organ donor registration rates.

213 Increases in organ donor registration were consistently observed in e

214 vehicle (MV) clerks are at the epicenter of organ donor registration.

215 cognitive and attitudinal dimensions impact organ donor registration.

216 The goal of this study was to increase organ donor registrations at the Department of Motorized

217 r registration page, and had 9000 documented organ donor registrations.

218 considerable investment in the promotion of organ donor registries.

219 d seven hundred eight individuals joined the organ donor registry (95% confidence interval [95% CI],

220 The number of deceased organ donors remains stable but donor age is increasing.

221 luded if they were declared brain dead, were organ donors, required high-frequency ventilation, or if

222 irst two years of life, as compared to adult organ donors, revealing early compartmentalization of T

223 and mucosal tissues obtained from individual organ donors, revealing tissue-intrinsic compartmentaliz

224 ers are an inconsistent metric for assessing organ donor risk, irrespective of HIV status.

225 recent EEEV activity in counties nearby the organ donor's county of residence.

226 WNV RNA was retrospectively detected in the organ donor's serum.

227 tudies are derived from human autopsy and/or organ donor samples, which lack in vivo functional and m

228 hirty-two of 3,555 (0.9%) potential deceased organ donors screened during the study period showed a p

229 es the use of nucleic acid testing (NAT) for organ donor screening.

230 ital of Milan and 480 samples of prepandemic organ donor sera collected in 2010-2012.

231 Nondiabetic organ donors served as controls.

232 Nevertheless, with the continuing organ donor shortage for cardiac transplantation, left v

233 In some regions, the organ donor shortage has resulted in a substantial incre

234 BACKGROUND.: Due to ongoing organ donor shortage, an increasing number of adult live

235 ure (FHF), but its use is limited because of organ donor shortage, associated high costs, and the req

236 c death (DCD) donors are used in view of the organ donor shortage.

237 Despite a national organ-donor shortage and a growing population of patient

238 Organ donor shortages continue to persist, especially in

239 Potential organ donors should be assessed for unexplained fever an

240 Potential organ donors should be carefully screened for a history

241 Options for greater public recognition for organ donors should be explored.

242 testing (NAT) for the screening of potential organ donors should be reserved to high-risk donors.

243 ial, targeted mild hypothermia in brain-dead organ donors significantly reduced the incidence of dela

244 Results: Organ donor simvastatin treatment significantly reduced

245 nt-based risk factors for PNF independent of organ donor source.

246 on were offered to those considering the new organ donor status.

247 When blood supply in a deceased organ donor stops, ischemic injury starts.

248 No pretransplant or organ donors tested positive for SARS-CoV-2.

249 dance is made the dominant principle guiding organ donor testing, an unintended consequence may be an

250 ation (FPA) registration before death become organ donors than those not personally consenting.

251 f a severe shortage of kidneys from deceased organ donors that limits access to transplantation for m

252 S) changed the criteria intended to identify organ donors that put the associated organ recipients at

253 Compared with the standard risk deceased organ donor, the PHS donor was younger, male, died from

254 012, 96,028 (3.3%) were a "possible deceased-organ donor." The two proposed metrics of OPO performanc

255 Using our organ donor tissue resource, we analyzed cDC subset dist

256 ing the transmission of rabies virus from an organ donor to multiple recipients underscores the chall

257 unique tissue resource derived from healthy organ donors to deeply characterize human B-cell compart

258 lower esophageal sphincter (N-LES) of human organ donors to examine the physiologic signal transduct

259 rt the concept of extending the criteria for organ donors to include modest coronary atherosclerosis.

260 ding death and appropriately refer potential organ donors to the local organ procurement organization

261 even intermittent hypoxia (e.g., in deceased organ donors) to protect from liver IRI.

262 rospective longitudinal observation study of organ donors treated at a major metropolitan level I tra

263 Serum collected from the organ donor upon hospital admission tested negative, but

264 LV-1 transmission event caused by a multiple organ donor was investigated.

265 The recipient of a kidney from the same organ donor was not affected.

266 Serum from the organ donor was positive for WNV IgM but negative for WN

267 ts' knowledge about how to register to be an organ donor was the dominant dimension for donor registr

268 Mosquito-borne transmission of EEEV to the organ donor was the likely source of infection.

269 The value of registrants in terms of organ donors was computed based on a registrant's age-de

270 e Program for Reimbursing Expenses of Living Organ Donors was launched in the province of Ontario, Ca

271 ctional hemodynamic monitoring in brain-dead organ donors, we test the hypothesis that donor preload

272 Two additional recipients from the same organ donor were identified, their clinical and exposure

273 In total, 55 potential organ donors were admitted to the ICU to incorporate org

274 Kidney tissue samples obtained from organ donors were analyzed by using flow cytometry for c

275 Positive ZIKV tests in local deceased organ donors were investigated from 6/2016 to 1/2017.

276 e focused on increasing the number of living organ donors, which in 2001 for the first time exceeded

277 t influence individuals' decisions to become organ donors, which may be effectively targeted by inter

278 the residual pancreatic islets of a deceased organ donor who had T1D.

279 islets from six DiViD study patients and two organ donors who died at the onset of T1D, and the findi

280 s from the residual pancreatic islets of two organ donors who had T1D also recognize HIPs.

281 priority in kidney allocation to prior live organ donors who require a kidney transplant.

282 nd biceps specimens obtained from brain-dead organ donors who underwent MV (15-176 h) and age-matched

283 8-month-old rats and in human islets from 53 organ donors with ages ranging from 17 to 74 years.

284 large cohort of JDRF Network for Pancreatic Organ Donors With Diabetes (nPOD) human pancreata across

285 ude patients from the Network for Pancreatic Organ Donors with Diabetes (U.S.) and Diabetes Virus Det

286 ioid epidemic has resulted in an increase in organ donors with hepatitis C virus (HCV) infection in t

287 sed by adapting existing approaches used for organ donors with hepatitis.

288 with horizontal strabismus and from deceased organ donors with normal EOMs.

289 g T cells from inflamed pancreatic islets of organ donors with recent-onset T1D.

290 ed in an increasing number and proportion of organ donors with substance use disorder, and particular

291 Studies of organ donors with T1D that have examined T cells in panc

292 the reconciliation of an increased need for organ donors with the concern for donor safety.

293 gical examination of pancreata from diabetic organ donors with the goal of providing a foundation for

294 alpha-cell mass in pancreata recovered from organ donors with type 1 diabetes (n = 80), as well as f

295 to HIPs are found in the residual islets of organ donors with type 1 diabetes (T1D).

296 om inflamed pancreatic islets of three young organ donors with type 1 diabetes with a short disease d

297 Examination of pancreata from age-matched organ donors with type 2 diabetes mellitus (DM) treated

298 y six times higher than the number of actual organ donors, with the greatest loss of potential due to

299 ion (DiViD) study, compared with islets from organ donors without diabetes.

300 lapse undergoing mitral valve repair or from organ donors without mitral valve disease.